Hepatopatías esteatósicas dismetabólicas

European Association for the Study of the Liver, 2016, EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease, J Hepatol, 64, 1388, 10.1016/j.jhep.2015.11.004 Chalasani, 2018, The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases, Hepatology, 67, 328, 10.1002/hep.29367 Bellentani, 2017, The epidemiology of non-alcoholic fatty liver disease, Liver Int, 37, 81, 10.1111/liv.13299 Ma, 2017, Bidirectional analysis between fatty liver and cardiovascular disease risk factors, J Hepatol, 66, 390, 10.1016/j.jhep.2016.09.022 Canivet, 2017, Génétique et épigénétique dans la non-alcoholic fatty liver disease, Hepato Gastro, 24, 719 Anty, 2017, Stéatoses hépatiques non alcooliques : histoire naturelle, physiopathologie et démarche diagnostique, Hepato Gastro, 24, 702 Rowe, 2018, Too much medicine: overdiagnosis and overtreatment of non-alcoholic fatty liver disease, Lancet Gastroenterol Hepatol, 3, 66, 10.1016/S2468-1253(17)30142-5 Alberti, 2009, Circulation, 120, 1640, 10.1161/CIRCULATIONAHA.109.192644 Boursier, 2017, Diagnostic non invasif des lésions hépatiques dans la non-alcoholic fatty liver disease, Hepato Gastro, 24, 727 Bedossa, 2014, Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease, Hepatology, 60, 565, 10.1002/hep.27173 Angulo, 2007, The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD, Hepatology, 45, 846, 10.1002/hep.21496 Calzadilla, 2016, The natural course of nonalcoholic fatty liver disease, Int J Mol Sci, 17, 774, 10.3390/ijms17050774 Singh, 2015, Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatiti. A systematic review and meta-analysis of paired biopsy studies, Clin Gastroenterol Hepatol, 13, 643, 10.1016/j.cgh.2014.04.014 Targher, 2016, Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis, J Hepatol, 65, 589, 10.1016/j.jhep.2016.05.013 Vilar-Gomez, 2015, Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatoheopatitis, Gastroenterology, 149, 367, 10.1053/j.gastro.2015.04.005 Boyle, 2018, The bidirectional impacts of alcohol consumption and the metabolic syndrome: cofactors for progressive fatty liver disease, J Hepatol, 68, 251, 10.1016/j.jhep.2017.11.006 Lassailly, 2017, Traitement de la stéatohépatite non alcoolique : des mesures hygiéno-diététiques à la chirurgie bariatrique, Hepato Gastro, 24, 733